PRReleasevia Quantisnow
Kiromic BioPharma Inc. logo

Kiromic BioPharma Reports Tumor Volume Decrease in Two Patients Enrolled in Deltacel-01

ByQuantisnow··Wall Street's wire, on your screen.
Kiromic BioPharma (KRBP) stockprice, earnings, owners and insider trades

Ask Ellis, your AI research assistant, about this story

Keep researching KRBP

Quantisnow market dataNASDAQ
Kiromic BioPharma Inc. logo
KRBP
Kiromic BioPharma Inc.
Market cap
30-day
Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Listed since
2020
Get push alerts for KRBP

Follow KRBP and get a push notification the moment its next story breaks.

Kiromic BioPharma (KRBP) stock

Work at Kiromic BioPharma? See what ChatGPT tells investors about Kiromic BioPharma.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRBP (Kiromic BioPharma Inc.) and more on Quantisnow.

Is something on this page wrong? Request a change